160 related articles for article (PubMed ID: 32058215)
21. Diffusion kurtosis imaging and tumour microstructure for monitoring response to radiotherapy in human nasopharyngeal carcinoma xenografts.
Zheng X; Chen Y; Zheng D; Xiao Y; Chen J; Pan J; Chen W
Jpn J Clin Oncol; 2020 May; 50(5):548-555. PubMed ID: 32009176
[TBL] [Abstract][Full Text] [Related]
22. The role of technetium-99m methoxyisobutyl isonitrile scintigraphy in predicting the therapeutic effect of chemotherapy against nasopharyngeal carcinoma.
Wang XS; Zhang YJ; Liu XL; Zhou ZR; Hu CS; Eisbruch A
Cancer; 2011 Jun; 117(11):2435-41. PubMed ID: 24048791
[TBL] [Abstract][Full Text] [Related]
23. Depicting Changes in Tumor Biology in Response to Cetuximab Monotherapy or Combination Therapy by Apoptosis and Proliferation Imaging Using
Heinzmann K; Nguyen QD; Honess D; Smith DM; Stribbling S; Brickute D; Barnes C; Griffiths J; Aboagye E
J Nucl Med; 2018 Oct; 59(10):1558-1565. PubMed ID: 29794225
[TBL] [Abstract][Full Text] [Related]
24. Imaging assessment of cardioprotection mediated by a dodecafluoropentane oxygen-carrier administered during myocardial infarction.
Liu Z; Barber C; Gupta A; Wan L; Won YW; Furenlid LR; Chen Q; Desai AA; Zhao M; Bull DA; Unger EC; Martin DR
Nucl Med Biol; 2019 Mar; 70():67-77. PubMed ID: 30772168
[TBL] [Abstract][Full Text] [Related]
25. Cetuximab or Nimotuzumab Versus Cisplatin Concurrent with Radiotherapy for Local-Regionally Advanced Nasopharyngeal Carcinoma: a Meta-analysis.
Liang ZG; Lin GX; Ye JX; Li Y; Li L; Qu S; Liang X; Zhu XD
Asian Pac J Cancer Prev; 2018 May; 19(5):1397-1404. PubMed ID: 29802706
[TBL] [Abstract][Full Text] [Related]
26. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
[TBL] [Abstract][Full Text] [Related]
27. Experimental study of nasopharyngeal carcinoma radionuclide imaging and therapy using transferred human sodium/iodide symporter gene.
Zhong X; Shi C; Gong J; Guo B; Li M; Xu H
PLoS One; 2015; 10(1):e0117053. PubMed ID: 25615643
[TBL] [Abstract][Full Text] [Related]
28. Differential lung uptake of 99mTc-hexamethylpropyleneamine oxime and 99mTc-duramycin in the chronic hyperoxia rat model.
Clough AV; Audi SH; Haworth ST; Roerig DL
J Nucl Med; 2012 Dec; 53(12):1984-91. PubMed ID: 23086010
[TBL] [Abstract][Full Text] [Related]
29. Imaging of therapy-induced apoptosis using (99m)Tc-HYNIC-annexin V in thymoma tumor-bearing mice.
Wong E; Kumar V; Howman-Giles RB; Vanderheyden JL
Cancer Biother Radiopharm; 2008 Dec; 23(6):715-26. PubMed ID: 19111046
[TBL] [Abstract][Full Text] [Related]
30. Enhanced therapeutic efficacy of adenovirus-mediated interleukin-24 gene therapy combined with ionizing radiotherapy for nasopharyngeal carcinoma.
Liu J; Zhang Y; Sun P; Xie Y; Xiang J; Yang J
Oncol Rep; 2013 Sep; 30(3):1165-74. PubMed ID: 23783436
[TBL] [Abstract][Full Text] [Related]
31. Understanding the in vivo uptake kinetics of a phosphatidylethanolamine-binding agent (99m)Tc-Duramycin.
Audi S; Li Z; Capacete J; Liu Y; Fang W; Shu LG; Zhao M
Nucl Med Biol; 2012 Aug; 39(6):821-5. PubMed ID: 22534031
[TBL] [Abstract][Full Text] [Related]
32. Bortezomib and SAHA synergistically induce ROS-driven caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus.
Hui KF; Lam BH; Ho DN; Tsao SW; Chiang AK
Mol Cancer Ther; 2013 May; 12(5):747-58. PubMed ID: 23475956
[TBL] [Abstract][Full Text] [Related]
33. Molecular Imaging of Apoptosis in Atherosclerosis by Targeting Cell Membrane Phospholipid Asymmetry.
Chaudhry F; Kawai H; Johnson KW; Narula N; Shekhar A; Chaudhry F; Nakahara T; Tanimoto T; Kim D; Adapoe MKMY; Blankenberg FG; Mattis JA; Pak KY; Levy PD; Ozaki Y; Arbustini E; Strauss HW; Petrov A; Fuster V; Narula J
J Am Coll Cardiol; 2020 Oct; 76(16):1862-1874. PubMed ID: 33059832
[TBL] [Abstract][Full Text] [Related]
34. Treatment of Hepatocellular Carcinoma by Intratumoral Injection of
Zhou J; Hu P; Si Z; Tan H; Qiu L; Zhang H; Fu Z; Mao W; Cheng D; Shi H
Front Bioeng Biotechnol; 2019; 7():319. PubMed ID: 31799244
[No Abstract] [Full Text] [Related]
35. DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas.
Liao WH; Yang LF; Liu XY; Zhou GF; Jiang WZ; Hou BL; Sun LQ; Cao Y; Wang XY
BMC Cancer; 2014 Nov; 14():835. PubMed ID: 25407966
[TBL] [Abstract][Full Text] [Related]
36. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY
J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743
[TBL] [Abstract][Full Text] [Related]
37. Treatment of nasopharyngeal carcinoma cells with the histone-deacetylase inhibitor abexinostat: cooperative effects with cis-platin and radiotherapy on patient-derived xenografts.
Gressette M; Vérillaud B; Jimenez-Pailhès AS; Lelièvre H; Lo KW; Ferrand FR; Gattolliat CH; Jacquet-Bescond A; Kraus-Berthier L; Depil S; Busson P
PLoS One; 2014; 9(3):e91325. PubMed ID: 24618637
[TBL] [Abstract][Full Text] [Related]
38. Apigenin enhances the antitumor effects of cetuximab in nasopharyngeal carcinoma by inhibiting EGFR signaling.
Hu WJ; Liu J; Zhong LK; Wang J
Biomed Pharmacother; 2018 Jun; 102():681-688. PubMed ID: 29604587
[TBL] [Abstract][Full Text] [Related]
39. Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma.
You R; Sun R; Hua YJ; Li CF; Li JB; Zou X; Yang Q; Liu YP; Zhang YN; Yu T; Cao JY; Zhang MX; Jiang R; Mo HY; Guo L; Cao KJ; Lin AH; Qian CN; Sun Y; Ma J; Chen MY
Int J Cancer; 2017 Sep; 141(6):1265-1276. PubMed ID: 28577306
[TBL] [Abstract][Full Text] [Related]
40. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis.
Xu Z; Fang S; Zuo Y; Zhang Y; Cheng R; Wang Q; Yang Z; Cai W; Ma J; Yang X; Gao G
Cancer Sci; 2011 Oct; 102(10):1789-98. PubMed ID: 21707863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
